Filing Details

Accession Number:
0001179110-14-010388
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-06-13 18:34:49
Reporting Period:
2014-06-12
Filing Date:
2014-06-13
Accepted Time:
2014-06-13 18:34:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
896264 Usana Health Sciences Inc USNA Medicinal Chemicals & Botanical Products (2833) 870500306
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1203343 Dave Wentz 3838 West Parkway Blvd
Salt Lake City UT 84120
C.e.o. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-06-12 4,081 $35.47 478,036 No 4 M Direct
Common Stock Disposition 2014-06-12 4,081 $75.52 473,955 No 4 S Direct
Common Stock Acquisiton 2014-06-13 1,220 $35.47 475,175 No 4 M Direct
Common Stock Disposition 2014-06-13 1,220 $75.50 473,955 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock-Settled Stock Appreciation Rights Disposition 2014-06-12 7,698 $0.00 7,698 $35.47
Common Stock Stock-Settled Stock Appreciation Rights Disposition 2014-06-13 2,302 $0.00 2,302 $35.47
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
42,302 2014-04-27 2015-10-27 No 4 M Direct
40,000 2014-04-27 2015-10-27 No 4 M Direct
Footnotes
  1. The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II.
  2. Weighted average price. Price range in multiple transactions was $75.50 to $75.62, inclusive.